Natures Sunshine Products Inc is a natural health and wellness company mainly engaged in the manufacturing and direct selling of nutritional and personal care products... Show more
Nature's Sunshine Products, Inc., a manufacturer of nutritional supplements and personal care products, does not pay a regular dividend to shareholders. The current dividend yield on NATR is 0%, and the company has no forward dividend or established quarterly payment schedule. Rather than functioning as a dividend growth stock or a high-yield income stock, the company has chosen to retain earnings and return capital through opportunistic share repurchases. The last cash distribution was a $1.00 per share special dividend declared in March 2021, and no ordinary dividends have followed since 2017. As a result, dividend investors seeking predictable quarterly or monthly income will find no recurring payout here, and NATR should be viewed as a non-dividend-paying equity at present.
Nature's Sunshine Products has a dividend record stretching back more than three decades, but its payouts have been inconsistent rather than steadily growing. According to historical records, the company has made roughly 102 dividend payments since 1989. For a period in the mid-2010s it paid modest quarterly dividends of $0.10 per share, but these distributions were discontinued by 2017. The company then went several years without a payout before issuing a $1.00 per share special dividend in March 2021, with an ex-dividend date of March 26, 2021, and payment on April 9, 2021. This on-again, off-again pattern means NATR does not maintain any meaningful dividend growth streak, and its long-term capital return strategy has shifted toward share buybacks rather than reliable cash distributions.
Because the company pays no dividend, its payout ratio — the share of earnings distributed to shareholders — is effectively 0%, and there is no recurring dividend obligation to evaluate for sustainability. That said, the company's financial position is strong enough to support a dividend if management chose to introduce one. NATR operates with no long-term debt and has reported a robust cash balance of roughly $93.9 million, alongside positive free cash flow. These factors provide ample earnings and cash flow coverage for a future distribution. Management has instead prioritized reinvestment in digital and regional growth and share repurchases. In short, the absence of a dividend reflects a strategic choice rather than financial distress, and the underlying balance sheet offers meaningful headroom should the board decide to restore a payout.
Within the nutritional supplement and direct-selling industry, dividend policies vary widely, and NATR sits at the lower end of the income spectrum with its 0% yield. Several similarly sized peers in the personal products and nutrition space also favor modest or irregular distributions, with many directing excess cash toward buybacks, product development, or international expansion. Compared with larger consumer staples and wellness companies that offer consistent quarterly dividends, NATR delivers no recurring income and therefore does not compete for yield-oriented capital. For investors measuring the stock against dividend-paying peers, the company ranks below average on current income, though its debt-free balance sheet and cash position distinguish it from more leveraged, higher-yielding rivals in the sector.
Tickeron's AI Screener is an AI-powered stock and exchange-traded fund (ETF) discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener can also help identify dividend stocks, income-focused investments, trending stocks, breakout candidates, and emerging market opportunities more efficiently than manual screening. If you are searching for yield-paying equities or high-conviction ideas, explore the AI Screener to streamline your research.
For investors whose primary goal is recurring income, NATR is unlikely to be a suitable holding, given its 0% dividend yield and the absence of any current payout plan. The stock may appeal more to growth-oriented and total-return investors who value the company's debt-free balance sheet, positive free cash flow, and ongoing buyback activity. Long-term investors comfortable with capital-appreciation potential and occasional special distributions could find the equity interesting, while conservative income investors and retirees seeking reliable quarterly income would generally need to look elsewhere. The company's financial flexibility leaves the door open to a future dividend reinstatement, but until management announces a formal payout policy, the stock should not be considered a dividend investment.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
a manufacturer of nutritional and personal care products
Industry FoodMajorDiversified